Sree Rayalaseema Hi-Strength Hypo Q2 Results 2026: PAT ₹33 Cr +44%
Q2 FY27 results statement: what the company reported on revenue, margins and capex.
- Revenue
- ₹246Cr
- +35.2% YoY
- +16.6% QoQ
- Net profit
- ₹33Cr
- +43.5% YoY
- +32% QoQ
- Margin
- 14%
- −1 pp YoY
- 0 pp QoQ
Top 10 Chemicals & Petrochemicals companies on management guidance
See the sector's top 10 — free with your mobile number.
Sree Rayalaseema Hi-Strength Hypo Ltd Q2 FY27 key numbers
- Revenue
- Quarterly Revenue (Standalone) for Q2 Sep 2026: ₹24,641.22 lakhs.
As stated in Sree Rayalaseema Hi-Strength Hypo Ltd's Q2 FY27 results statement · published 14 Nov 2026. Reported figures, not investment advice.
Based on Sree Rayalaseema Hi-Strength Hypo Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.
The short version
Quarterly Revenue (Standalone) for Q2 Sep 2026: ₹24,641.22 lakhs. EBITDA for the quarter ended 30.09.2026: ₹5,912.1 lakhs, up 25.3% YoY (₹4,716.4 lakhs for 30.09.2025).
From Sree Rayalaseema Hi-Strength Hypo Ltd's Q2 FY27 earnings-call transcript · updated 14 Nov 2026.
How did Sree Rayalaseema Hi-Strength Hypo's revenue grow in the September 2026 quarter?
- Quarterly Revenue (Standalone) for Q2 Sep 2026: ₹24,641.22 lakhs
- Quarterly Revenue for Q2 Sep 2025: ₹18,238.99 lakhs
- Year-on-Year Revenue Growth: Approx. 35.1% increase [(24,641.22 - 18,238.99) / 18,238.99 × 100]
- Total Revenue (Standalone, including other income) Q2 Sep 2026: ₹25,660.36 lakhs vs ₹18,947.37 lakhs in Q2 Sep 2025
2 more points from Sree Rayalaseema Hi-Strength Hypo Ltd's call on revenue
Create a free account to keep reading this call
What happened to Sree Rayalaseema Hi-Strength Hypo's margins in Q2 FY27?
EBITDA for the quarter ended 30.09.2026: ₹5,912.1 lakhs, up 25.3% YoY (₹4,716.4 lakhs for 30.09.2025)
Locked: what Sree Rayalaseema Hi-Strength Hypo Ltd said on margins
Also locked on this page: fundraising, order book
Free account, 30 seconds. No card needed.
What capex is Sree Rayalaseema Hi-Strength Hypo planning?
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is Sree Rayalaseema Hi-Strength Hypo raising money or cutting debt?
There were no borrowings under long-term borrowings for the half year ended 30th September 2026.
Locked: what Sree Rayalaseema Hi-Strength Hypo Ltd said on fundraising
Also locked on this page: margins, order book
Free account, 30 seconds. No card needed.
How big is Sree Rayalaseema Hi-Strength Hypo's order book?
See what Sree Rayalaseema Hi-Strength Hypo Ltd said on order book & pipeline — free account, 30 seconds.
Sree Rayalaseema Hi-Strength Hypo Ltd — Quarterly revenue & net profit
Sree Rayalaseema Hi-Strength Hypo Ltd Q2 FY27 results — key figures
| ₹ Cr | Q2 FY27 |
|---|---|
| Revenue | 246 |
| Operating profit (EBITDA) | 35 |
| Operating margin | 14.3% |
| Profit before tax | 44 |
| Net profit (PAT) | 33 |
| EPS (₹) | 19.18 |
Source: Sree Rayalaseema Hi-Strength Hypo Ltd's results filing to NSE (consolidated), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹246 Cr, net profit ₹33 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →More Q2 FY27 results in Chemicals & Petrochemicals
Continue your research
Others in Chemicals & Petrochemicals this season
- Mangalam Organic (Q2 FY27)
78% increase. Key results statement takeaways from Mangalam Organics Ltd's Q2 FY27 results statement — and how it ranks against sector peers.
- Indian Emuls (Q2 FY27)
This represents a year-on-year increase of approximately 74%. Key results statement takeaways from Indian Emulsifiers Ltd's Q2 FY27 results statement — and how
- Fineotex Chem (Q2 FY27)
Q2 FY27 Revenue from Operations: ₹387.65 crore, up 181.51% YoY from ₹137.71 crore in Q2 FY26. Key investor presentation takeaways from Fineotex Chemical Ltd's Q
- Omkar Speciality Chemicals (Q2 FY27)
Revenue from operations for the quarter ended 30th September 2026: ₹0 Lakhs (No revenue generated). Key results statement takeaways from Omkar Speciality Chemic
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Sree Rayalaseema Hi-Strength Hypo Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Sree Rayalaseema Hi-Strength Hypo Ltd Q2 FY27 results?
Quarterly Revenue (Standalone) for Q2 Sep 2026: ₹24,641.22 lakhs. EBITDA for the quarter ended 30.09.2026: ₹5,912.1 lakhs, up 25.3% YoY (₹4,716.4 lakhs for 30.09.2025).
What is Sree Rayalaseema Hi-Strength Hypo Ltd share price analysis?
Sree Rayalaseema Hi-Strength Hypo Ltd currently shows a neutral. The stock trades at a P/E of 9.1 with a market cap of ₹894 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Sree Rayalaseema Hi-Strength Hypo Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.